Get startedLog in
    Picture of Medicinova logo

    MNOV — Medicinova News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapNeutral
    All News

    Brief: Medicinova Announces Results Of Studies Under BARDA Contract To Develop MN 166 (Ibudilast)

    Picture of Medicinova logoMedicinova
    28/09/2023 24:06
    Sept 27 (Reuters) - MediciNova Inc  MNOV.O :
    * MEDICINOVA ANNOUNCES RESULTS OF STUDIES UNDER BARDA
CONTRACT TO
DEVELOP MN 166 (IBUDILAST) AS A MEDICAL COUNTERMEASURE AGAINST
CHLORINE GAS-INDUCED LUNG INJURY
    * MN-166 (IBUDILAST) WAS WELL TOLERATED AND NO SAFETY
CONCERNS
WERE OBSERVED IN SINGLE-DOSE STUDY

Source text for Eikon:  ID:nGNX5pDHKq 
Further company coverage:  MNOV.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Medicinova

    See all news